HANSEN-TECHNOLOGIES
Hansen Technologies (ASX:HSN) is pleased to announce today that it has signed a new agreement with wilhelm.tel GmbH, a multi-service provider of telecommunications services in Germany.
Under the terms of this agreement, Hansen will upgrade wilhelm.tel’s existing version of Hansen CCB–NavibillingCX to the latest version and replace their existing CRM system. As a result of this upgrade, wilhelm.tel will receive enhanced customer care, billing and product management capabilities, as well as improved accounting and provisioning processes.
Jens Seedorff, General Manager, wilhelm.tel, commented: “Our partnership with Hansen has a strong track record of operational efficiency. It was based on this that we decided that Hansen were the ideal vendor to help further enable the next chapter of our digital transformation initiative – as we confront not only changing customer expectations, but a telecommunications industry undergoing a major degree of transition as well.”
Scott Weir, Regional President, EMEA, Hansen Technologies, commented : “wilhelm.tel is a longstanding customer of Hansen, supporting their customers for over twenty years with our NavibillingCX product. We are excited to have been selected to not only upgrade wilhelm.tel to our new version of NavibillingCX – based on Microsoft Business Central – but also introduce significant new functionality that improves the customer experience, while accelerating time-to-market. wilhelm.tel’s commitment to Hansen and our product demonstrates the strength of our relationship and provides a strong foundation to future-proof their business for many years to come.”
Hansen CCB , part of the Create-Deliver-Engage Suite of software, provides flexible rating, billing and customer care for communications and pay-TV service providers. Part of the Hansen CCB product family, NavibillingCX is a tailor-made unified solution for fixed and mobile telephony, as well as broadband, IP services, cable TV and interconnect billing. It provides end-to-end customer lifecycle management, and also delivers full ERP capabilities including financial controls, reporting and analytics via Microsoft integration.
For further information about Hansen Technologies, please visit www.hansencx.com .
About Hansen Technologies
Hansen Technologies (ASX: HSN) is a leading global provider of software and services to the energy, water and communications industries. With its award-winning software portfolio, Hansen serves 580+ customers in over 80 countries, helping them to create, sell, and deliver new products and services, manage and analyze customer data, and control critical revenue management and customer support processes.
For more information, visit www.hansencx.com
About wilhelm.tel
Founded in 1999 as a completely owned subsidiary of Stadtwerke Norderstedt, wilhelm.tel GmbH is a nationwide pioneer among operators of high-performance fiber optic networks. From the very beginning, the company has consistently followed a Fiber-to-the-Building strategy, directly connecting every building to its fiber optic network. Since 2020, wilhelm.tel has been increasingly laying fiber optics right up to apartment buildings, thus guaranteeing maximum bandwidth to the customer.
The fiber-optic network, which currently comprises around 2,500 kilometers, has long since crossed the city limits of its home market in Norderstedt and is growing steadily in the direction of Schleswig-Holstein, Hamburg and Lower Saxony. wilhelm.tel regularly sets new standards nationwide with pioneering technology and products and services that are precisely tailored to customer needs. With a resulting market share of up to 90 per cent, wilhelm.tel is considered the most sought-after provider in the Hamburg metropolitan region.
In 2019, wilhelm.tel GmbH, with 130 employees, generated an annual turnover of 73 million euros.
For more information on Wilhelm.tel, visit https://www.wilhelm-tel.de/
View source version on businesswire.com: https://www.businesswire.com/news/home/20210817005190/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 00:49:00 CET | Press release
‒ Named Most Respected Public Semiconductor Company Achieving $100 Million to $500 Million in Annual Sales ‒ Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom